IFNG and graft versus host disease: Our data complement other studies which illustrate the role of IFN-γ signaling in mediating GVHD induction and the utility of monoclonal antibodies targeting IFN-γ, which may decrease the risk of graft rejection in allo-HCT models [47, 48].